Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1 014 JPY | +0,40 % | -0,78 % | -19,01 % |
Métier
Nombre d'employés: 1 793
Ventes par activité
JPY en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Reagent
84,4
%
| 54 605 | 80,7 % | 65 925 | 84,4 % | +20,73 % |
Brokerage
10,5
%
| 11 426 | 16,9 % | 8 200 | 10,5 % | -28,23 % |
Genetic Medicine
3,4
%
| 148 | 0,2 % | 2 640 | 3,4 % | +1 683,78 % |
Equipment
1,8
%
| 1 518 | 2,2 % | 1 375 | 1,8 % | -9,42 % |
Ventes par région
JPY en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Japan
58,4
%
| 34 076 | 50,3 % | 45 667 | 58,4 % | +34,02 % |
United States
16,5
%
| 10 186 | 15,0 % | 12 886 | 16,5 % | +26,51 % |
China
13,8
%
| 11 908 | 17,6 % | 10 799 | 13,8 % | -9,31 % |
Europe
6,3
%
| 4 668 | 6,9 % | 4 949 | 6,3 % | +6,02 % |
Asia excluding Japan and China
4,5
%
| 6 614 | 9,8 % | 3 546 | 4,5 % | -46,39 % |
Others
0,4
%
| 244 | 0,4 % | 293 | 0,4 % | +20,08 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Director of Finance/CFO | 68 | 01/06/14 | |
Koichi Nakao
PSD | President | 61 | 01/04/02 |
Takuya Kakemi
ADM | Chief Administrative Officer | - | - |
Junichi Mineno
COO | Chief Operating Officer | 63 | 01/04/04 |
Director/Board Member | 60 | 01/01/09 | |
Masanobu Kimura
BRD | Director/Board Member | 60 | 01/05/13 |
Human Resources Officer | - | - | |
Akihiko Kita
AUD | Comptroller/Controller/Auditor | 64 | 01/04/05 |
Corporate Officer/Principal | - | - | |
Masahide Tamaki
AUD | Comptroller/Controller/Auditor | 64 | 01/04/05 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Hisashi Omiya
CHM | Chairman | 80 | 01/04/02 |
Masanobu Kimura
BRD | Director/Board Member | 60 | 01/05/13 |
Koichi Nakao
PSD | President | 61 | 01/04/02 |
Director of Finance/CFO | 68 | 01/06/14 | |
Director/Board Member | 60 | 01/01/09 | |
Junichi Mineno
COO | Chief Operating Officer | 63 | 01/04/04 |
Kazuko Kimura
BRD | Director/Board Member | 73 | 01/06/19 |
Nobuko Kawashima
BRD | Director/Board Member | 61 | 01/06/16 |
Director/Board Member | 52 | 01/06/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 120 415 600 | 47 065 600 ( 39,09 %) | 0 | 39,09 % |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Takara Bio Europe SAS
Takara Bio Europe SAS Medical SpecialtiesHealth Technology Takara BIO Europe SAS provides kits, reagents, instruments, and services that enable life sciences researchers to achieve their experimental objectives. It offers automation systems, stem cell research, real time PCR, nucleic acid purification, cloning, cell biology assays, gene function, antibodies, and ELISAs. The company is headquartered in Saint-Germain-en-Laye, France. |
Medical Specialties
|
Cellectis AB
Cellectis AB BiotechnologyHealth Technology Part of Takara Holdings, Inc., Cellectis AB is a Swedish company that manufactures and distributes stem cell-related products. The private company is based in Gothenburg, Sweden. Cellectis was acquired by Takara Bio, Inc. from Cellectis SA on September 04, 2014. |
Biotechnology
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-19,01 % | 795 M | |
+22,81 % | 47,9 Md | |
+46,56 % | 41,42 Md | |
-1,88 % | 40,7 Md | |
-6,20 % | 28,92 Md | |
+11,33 % | 25,55 Md | |
-21,00 % | 19,27 Md | |
-1,43 % | 12,15 Md | |
+30,73 % | 12,14 Md | |
-0,48 % | 11,99 Md |
- Bourse
- Actions
- Action 4974
- Société Takara Bio Inc.